Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy

Background: Limited evidence exists on the impact of adding a taxane, using endocrine therapy and carrying a deleterious germline BRCA mutation on ovarian reserve measured by anti-müllerian hormone (AMH) levels of young breast cancer patients receiving (neo)adjuvant cyclophosphamide- and anthracycli...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Lambertini, Matteo, Olympios, Nathalie, Lequesne, Justine, Calbrix, Céline, Fontanilles, Maxime, Loeb, Agnès, Leheurteur, Marianne, Demeestere, Isabelle, Di Fiore, Frédéric, Perdrix, Anne, Clatot, Florian
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6640206/
https://ncbi.nlm.nih.gov/pubmed/31355134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00575
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires